CLINICAL IMPACT OF BULKY MASS IN THE PATIENT WITH PRIMARY EXTRANODAL DIFFUSE LARGE B CELL LYMPHOMA TREATED WITH R-CHOP THERAPY

被引：0
|
作者：
Song, M. K. [1 ]
Chung, J. S. [1 ]
Lee, G. W. [2 ]
Oh, S. Y. [3 ]
Shin, H. J. [1 ]
Seol, Y. M. [1 ]
Cho, C. J. [1 ]
机构：
[1] Pusan Natl Univ Hosp, Pusan, South Korea
[2] Gyeongsang Natl Univ Hosp, Jinju, South Korea
[3] Dong A Med Ctr, Pusan, South Korea
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1558
引用
收藏
页码：617 / 617
页数：1
相关论文
共 50 条
  • [41] Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP
    Hara, Takeshi
    Tsurumi, Hisashi
    Goto, Naoe
    Kanemura, Nobuhiro
    Yoshikawa, Takeshi
    Kasahara, Senji
    Yamada, Toshiki
    Sawada, Michio
    Goto, Hideko
    Fukuno, Kenji
    Kitagawa, Jun-ichi
    Yasuda, Ichiro
    Katsumura, Naoki
    Takemura, Masao
    Takahashi, Takeshi
    Takami, Tsuyoshi
    Moriwaki, Hisataka
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (10) : 1421 - 1428
  • [42] Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment
    Hitz, Felicitas
    Connors, J. M.
    Gascoyne, R. D.
    Hoskins, P.
    Moccia, A.
    Savage, K. J.
    Sehn, L. H.
    Shenkier, T.
    Villa, D.
    Klasa, R.
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1839 - 1843
  • [43] Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP
    Nyman, Heidi
    Jerkeman, Mats
    Karjalainen-Lindsberg, Marja-Liisa
    Banham, Alison H.
    Leppa, Sirpa
    MODERN PATHOLOGY, 2009, 22 (08) : 1094 - 1101
  • [44] Prognostic Impact of Immunohistochemical Profile and Microvessel Density (MVD) in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP
    Cardesa, T.
    Gutierrez-Garcia, G.
    Climent, F.
    Arenillas, L.
    Serrano, S.
    Romagosa, V.
    Gonzalez-Barca, E.
    Campo, E.
    Lopez-Guillermo, A.
    Colomo, Ll
    LABORATORY INVESTIGATION, 2009, 89 : 256A - 256A
  • [45] Radiation Therapy After R-CHOP for Diffuse Large B-Cell Lymphoma: The Gain Remains
    Yahalom, Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) : 4105 - 4107
  • [46] Impact of comorbidity and relative dose intensity on outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP
    Masakazu Yamamoto
    Ikuko Suzuki
    Kouji Saitou
    Riko Tsumanuma
    Shuhei Okuyama
    Hiroaki Kumagai
    Eijiro Omoto
    Shinji Satoh
    Katsushi Tajima
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2995 - 3002
  • [47] Impact of comorbidity and relative dose intensity on outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP
    Yamamoto, Masakazu
    Suzuki, Ikuko
    Saitou, Kouji
    Tsumanuma, Riko
    Okuyama, Shuhei
    Kumagai, Hiroaki
    Omoto, Eijiro
    Satoh, Shinji
    Tajima, Katsushi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (11) : 2995 - 3002
  • [48] Prognostic Impact of Immunohistochemical Profile and Microvessel Density (MVD) in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP
    Cardesa, T.
    Gutierrez-Garcia, G.
    Climent, F.
    Arenillas, L.
    Serrano, S.
    Romagosa, V.
    Gonzalez-Barca, E.
    Campo, E.
    Lopez-Guillermo, A.
    Colomo, L. I.
    MODERN PATHOLOGY, 2009, 22 : 256A - 256A
  • [49] Prognostic impact of pretreatment albumin to globulin ratio in patients with diffuse large B-cell lymphoma treated with R-CHOP
    Kim, Seok-Hyun
    Go, Se-Il
    Seo, Jangho
    Kang, Myoung Hee
    Park, Sung Woo
    Kim, Hoon-Gu
    Lee, Gyeong-Won
    LEUKEMIA RESEARCH, 2018, 71 : 100 - 105
  • [50] Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP
    Sehn, Laurie H.
    Scott, David W.
    Chhanabhai, Mukesh
    Berry, Brian
    Ruskova, Anna
    Berkahn, Leanne
    Connors, Joseph M.
    Gascoyne, Randy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (11) : 1452 - 1457
12345